Qingdao Vland Biotech INC. (SHA:603739)
China
· Delayed Price · Currency is CNY 15.88
+0.46 (2.98%)
Mar 10, 2026, 3:00 PM CST
SHA:603739 Revenue
Qingdao Vland Biotech INC. had revenue of 363.60M CNY in the quarter ending September 30, 2025, with 8.09% growth. This brings the company's revenue in the last twelve months to 1.39B, up 9.97% year-over-year. In the year 2024, Qingdao Vland Biotech INC. had annual revenue of 1.32B with 10.16% growth.
Revenue (ttm)
1.39B
Revenue Growth
+9.97%
P/S Ratio
2.81
Revenue / Employee
906.15K
Employees
1,535
Market Cap
3.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.32B | 121.86M | 10.16% |
| Dec 31, 2023 | 1.20B | 35.74M | 3.07% |
| Dec 31, 2022 | 1.16B | 12.34M | 1.07% |
| Dec 31, 2021 | 1.15B | 190.57M | 19.85% |
| Dec 31, 2020 | 960.25M | 113.47M | 13.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boji Medical Technology | 770.19M |
| Baolingbao Biology | 2.69B |
| Zhejiang Wecome Pharmaceutical Company | 131.67M |
| Shenzhen Bioeasy Biotechnology | 251.83M |
| Shanghai Shen Lian Biomedical | 288.27M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Guanhao Biotech | 392.83M |
| Hinova Pharmaceuticals | 20.67M |